FIELD: medicine, in correction of endothelial dysfunction.
SUBSTANCE: endothelial dysfunction is modeled in white rats by intraperitoneal administering of endothelial N-nitro-L-arginin methyl ester syntase in dose of 25 mg/kg for 7 days. Further correction is carried out by administering of polyclonal rabbit antibodies to human endothelial nitrogen oxide synthase for C12, C30, C200 for 7 days.
EFFECT: effective correction of endothelial dysfunction.
1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING LOZARTAN IN COMPLEX WITH ADMIXTURE OF SOLUTIONS OF HOMEOPATHIC DELUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO ENDOTHELIAL SYNTHASE OF HUMAN NITROGEN OXIDE-C12, C30, C200 | 2007 |
|
RU2343927C1 |
| METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH ENALAPRIL IN COMPLEX WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438189C1 |
| METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438191C1 |
| METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH LOZARTAN IN COMPLEX WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2437162C1 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES IN COMPLEX WITH SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2500425C2 |
| METHOD OF CORRECTING HYPERHOMOCYSTEIN-INDUCED ENDOTHELIAL DYSFUNCTION BY MIXTURE OF SOLUTIONS OF HOMEOPATHIC DILUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE- C12, C30, C200 | 2010 |
|
RU2425672C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-1 ANTIBODIES | 2011 |
|
RU2526150C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES | 2011 |
|
RU2477529C2 |
| METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION BY PHOSPHOGLIV PREPARATION AT L-NAME INDUCED DEFICIENCY OF NITROGEN OXIDE | 2008 |
|
RU2359668C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2421822C2 |
